Periodontal Inflammation and Epigenetics in Obese Individuals Study

This study aims to understand how deep cleaning (non-surgical periodontal therapy) affects the body's genetic switches (epigenetic modifications) in obese individuals with gum disease (periodontitis). Researchers will compare changes in these genetic switches, inflammation markers, and mouth bacteria in people with periodontitis who are obese versus those who are not obese. The study will look at these changes before and after deep cleaning. You may be able to join if you are an adult aged 18 to 75, have periodontitis, and have not had recent gum treatment or used tobacco. The goal is to see if deep cleaning leads to long-term changes in these genetic switches in obese individuals with gum disease.

Study design
This interventional study plans to enroll 40 participants, divided into two groups: obese with periodontitis and non-obese with periodontitis. The study will evaluate changes both at the start and after treatment.
What's involved
Participants will receive non-surgical periodontal therapy (deep cleaning). Measurements of host-specific epigenetic signatures, inflammatory cytokine profiles, and periodontal microbial composition will be taken at the beginning of the study (Baseline/Day 1).
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at Baseline/Day 1, but the study aims to monitor longitudinal changes, suggesting follow-up beyond this initial measurement. The exact duration is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07610902

Periodontal Inflammation and Epigenetics in Obese Individuals

Not Yet Recruiting
NAAges 18–75InterventionalBasic science
Louisiana State University Health Sciences Center in New Orleans
~40 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Non-surgical periodontal therapy will be administered

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Host-specific epigenetic signatures
Measured over Baseline/Day 1
+2 more outcomes measured
Obesity
Periodontitis
1 sites across 1 states
Louisiana1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults aged ≥18 years,
No history of periodontal therapy in the last 6 months,
No use of tobacco,
No history of pregnancy lactation or contraceptive medication.
Need to have a minimum of 20 teeth.

Exclusion

Had antimicrobial/antiviral therapy in the previous 3 months,
History of uncontrolled diabetes,
History of rheumatoid arthritis,
History of osteoporosis,
History of oral cancer,
Currently taking hormonal contraception,
If pregnant or lactating currently or prior 6 months,
Subjects on current weight loss drugs
If planning weight reduction surgery during the time of the study
Any other condition, disease or therapy with documented influence on oral inflammation and/or oral microbial environment.
  • Host-specific epigenetic signaturesBaseline/Day 1

    Gingival crevicular fluid and saliva will be analyzed to study epigenetic signatures

  • Inflammatory cytokine profilesBaseline/Day 1

    Gingival crevicular fluid and saliva will be analyzed to study inflammatory cytokine profiles.

  • Periodontal microbial compositionBaseline/Day 1

    Subgingival plague will be analyzed to study periodontal microbial composition